Hansoh Pharmaceutical Group Company Limited (HKG:3692)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
23.60
+1.45 (6.55%)
Mar 28, 2025, 4:08 PM HKT

Hansoh Pharmaceutical Group Company Company Description

Hansoh Pharmaceutical Group Company Limited, an investment holding company, engages in the research, development, production, and sale of pharmaceutical products in the People’s Republic of China.

The company provides products for therapeutic areas, including anti-infection, central nervous system, oncology, and metabolic and other diseases, as well as autoimmune diseases.

Its principal products include Ameile, Hansoh Xinfu, Pulaile, Zefei, Xintai, Xinmei, Gainuo, Tanneng, and Pulaitan; Hengmu, Mailingda, Hengsen, Oulanning, Ailanning, and Ameining; XINYUE; and Saint Luolai, Fulaimei, Ruibote, Fulaidi, Fulairui, Punuoan tablets, etc. It has licence agreements with GlaxoSmithKline Intellectual Property (No.4) Limited to develop, manufacture, and commercialize HS-20089 and HS-20093 for the treatment of patients with extensive-stage small-cell lung cancer (ES-SCLC) with disease progression on or after platinum-based chemotherapy; Biotheus Inc. to develop, produce, and commercialize bispecific antibody-drug conjugate product; and with Merck Sharp & Dohme LLC (MSD) to develop, manufacture, and commercialize HS-10535, an investigational pre-clinical oral small molecule glucagon-like peptide-1 (GLP-1) receptor agonist.

The company was founded in 1995 and is headquartered in Shanghai, China. Hansoh Pharmaceutical Group Company Limited is a subsidiary of Stellar Infinity Company Ltd.

Hansoh Pharmaceutical Group Company Limited
Country Cayman Islands
Founded 1995
Industry Drug Manufacturers - Specialty & Generic
Sector Healthcare
Employees 8,989
CEO Huijuan Zhong

Contact Details

Address:
287 Xiangke Road
Shanghai, 201210
China
Phone 86 40 0828 5227
Website hspharm.com

Stock Details

Ticker Symbol 3692
Exchange Hong Kong Stock Exchange
Fiscal Year January - December
Reporting Currency CNY
ISIN Number KYG549581067
SIC Code 2834

Key Executives

Name Position
Huijuan Zhong Chairlady, Chief Executive Officer and President
Dr. Aifeng Lyu Executive Director
Yuan Sun Executive Director
Min Hu Vice President and Chief Financial Officer
Dr. Chih-Hung Lee Chief of Science Officer
Chuanhe Xu Senior Vice President
Weiyong Sun Chief Commercial Officer
Shengli Zhong Joint Company Secretary and Senior Vice President
Yuen Ki Wong Joint Company Secretary